Zoetis, Merck, Boehringer, Elanco, Virbac and Ceva Lead Race for Share in $15.6 Billion Veterinary Vaccine Market

Global demand for livestock and companion animal vaccines is accelerating as disease prevention, food security concerns, and new vaccine technologies drive sustained growth across animal health markets.
  • Global veterinary vaccines market projected to reach $15.6 billion by 2031, up from $11 billion in 2025, representing a 6% CAGR.
  • Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Virbac and Ceva Santé Animale remain the industry’s leading players.
  • Growth is being fueled by rising livestock disease threats, zoonotic disease concerns, expanding pet ownership, and increasing investment in preventive healthcare.
  • Recombinant, vector-based and emerging mRNA vaccine technologies are reshaping product development pipelines.
  • Livestock vaccines continue to account for the largest market segment, driven by poultry, cattle and swine production.
  • Asia-Pacific is expected to be the fastest-growing regional market through 2031.

Major animal health companies are strengthening their positions in a veterinary vaccines market expected to reach $15.6 billion by 2031, according to a new report from Wissen Research.

Industry leaders including Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Virbac and Ceva Santé Animale continue to invest heavily in vaccine innovation as producers and pet owners place greater emphasis on disease prevention and herd health management.

Disease Prevention Driving Demand

The market’s growth is being supported by increasing concerns over livestock disease outbreaks, zoonotic disease transmission, and food security. Researchers noted that expanding commercial livestock production and rising pet ownership are creating sustained demand for preventive vaccination programs across both production and companion animal sectors.

Government-backed vaccination initiatives targeting diseases such as avian influenza, foot-and-mouth disease, and rabies are also contributing to vaccine adoption globally.

Advanced Vaccine Technologies Gain Momentum

The next phase of market growth is expected to come from newer vaccine platforms, including recombinant, vector-based, DNA and mRNA technologies.

Advances in genomic sequencing and reverse vaccinology are enabling faster vaccine development against emerging animal diseases, while multivalent vaccines continue to improve operational efficiency by protecting against multiple pathogens in a single administration. Thermostable formulations and needle-free delivery systems are also helping expand access in regions with limited infrastructure.

Strategic Moves Expand Market Reach

Recent industry activity highlights continued investment in vaccine portfolios and animal health capabilities.

In 2025, Vaxxinova International expanded its poultry vaccine business through the acquisition of Dechra Pharmaceuticals’ Avishield portfolio and related R&D assets, adding vaccines targeting infectious bronchitis, Gumboro disease and Newcastle disease.

Meanwhile, Hipra strengthened its presence in Latin America through a collaboration with Argentina-based Llamas Laboratories and Services aimed at expanding diagnostic capabilities for animal production.

Livestock Vaccines Remain Market Leader

Livestock vaccines continue to represent the largest segment of the global veterinary vaccines market, supported by increasing global demand for animal protein and ongoing efforts to control transboundary animal diseases. Poultry vaccines remain a particularly important growth driver given the scale of global poultry production and continued concerns over avian disease outbreaks.

Live attenuated vaccines currently account for a significant share of the market due to their ability to generate strong and long-lasting immune responses across multiple species and disease indications.

Asia-Pacific Emerges as Growth Engine

While North America remains the largest veterinary vaccines market due to its established animal health infrastructure and high pet ownership rates, Asia-Pacific is projected to deliver the strongest growth through 2031.

Expanding livestock populations, rising protein consumption, increasing pet ownership and government-supported disease control programs are creating significant opportunities across China, India and Southeast Asia.

Information sourced from the company’s press release and market report summary.

Additional Research: Browse the latest market research reports and industry insights from Wissen Research: https://www.wissenresearch.com/report/

Never Miss an Animal Health Story

Sign up for free to receive the latest veterinary news, product announcements, and industry developments.